[1] |
Nicolaides KH, Azar G, Byrne D, et al. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy[J]. BMJ, 1992, 304(6831):867-869. DOI: 10.1136/bmj.304.6831.867.
|
[2] |
Tang Y, Luo H, Mu D, et al. Early diagnosis of trisomy 21, trisomy 18 and trisomy 13 using nuchal translucency thickness and ductus venosus blood flow waveform in West China[J]. Mol Med Rep, 2019, 19(2):1349-1355. DOI: 10.3892/mmr.2018.9756.
|
[3] |
Chanprapaph P, Dulyakasem C, Phattanchindakun B. Sensitivity of multiple first trimester sonomarkers in fetal aneuploidy detection[J]. J Perinat Med, 2015, 43(3):359-365. DOI: 10.1515/jpm-2014-0201.
|
[4] |
Dane B, Dane C, Cetin A, et al. Pregnancy outcome in fetuses with increased nuchal translucency[J]. J Perinatol, 2008, 28(6):400-404. DOI: 10.1038/jp.2008.14.
|
[5] |
|
[6] |
Gu YZ, Nisbet DL, Reidy KL, et al. Hypoplastic nasal bone: a potential marker for facial dysmorphism associated with pathogenic copy number variants on microarray[J]. Prenat Diagn, 2019, 39(2):116-123. DOI: 10.1002/pd.5410.
|
[7] |
Węgrzyn P, Czuba B, Serafin D, et al. Nasal bone in screening for T21 at 11-13 +6 weeks of gestation - a multicenter study[J]. Ginekol Pol, 2016, 87(11):751-754. DOI: 10.5603/GP.2016.0082.
|
[8] |
|
[9] |
Prefumo F, Sairam S, Bhide A, et al. Maternal ethnic origin and fetal nasal bones at 11-14 weeks of gestation[J]. BJOG, 2004, 111(2):109-112. DOI: 10.1046/j.1471-0528.2003.00025.x-i1.
|
[10] |
Salomon LJ, Alfirevic Z, Bilardo CM, et al. ISUOG practice guidelines: performance of first-trimester fetal ultrasound scan[J]. Ultrasound Obstet Gynecol, 2013, 41(1):102-113. DOI: 10.1002/uog.12342.
|
[11] |
Sepulveda W, Wong AE, Dezerega V. First-trimester ultrasonographic screening for trisomy 21 using fetal nuchal translucency and nasal bone[J]. Obstet Gynecol, 2007, 109(5):1040-1045. DOI: 10.1097/01.AOG.0000259311.87056.5e.
|
[12] |
|
[13] |
Sparks AB, Struble CA, Wang ET, et al. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18[J]. Am J Obstet Gynecol, 2012, 206(4):319.e1-e9. DOI: 10.1016/j.ajog.2012.01.030.
|
[14] |
Herrera LG, Royero LR, Rodríguez NG, et al. Effectiveness of increased nuchal translucency in detecting pregnancies at risk for chromosomal abnormalities[J]. MediSur, 2014, 12(1):63-76.
|
[15] |
Agathokleous M, Chaveeva P, Poon LC, et al. Meta-analysis of second-trimester markers for trisomy 21[J]. Ultrasound Obstet Gynecol, 2013, 41(3):247-261. DOI: 10.1002/uog.12364.
|
[16] |
Ting YH, Lao TT, Lau TK, et al. Isolated absent or hypoplastic nasal bone in the second trimester fetus: is amniocentesis necessary?[J]. J Matern Fetal Neonatal Med, 2011, 24(4):555-558. DOI: 10.3109/14767058.2010.487140.
|
[17] |
Desai P , Chauhan B , Jhawar M. Outcome of pregnancies with isolated absent fetal nasal bone in the second trimester[J]. J Fetal Med, 2019, 6(4): 31-34.DOI: 10.1007/s40556-019-00196-9.
|